It could be a game-changer for the millions of Americans who suffer from sleep apnea. A new first-of-its-kind pill could ...

Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...

Air Voel is shining a spotlight on the latest generation of sleep apnea therapy with the AirSense 11 CPAP machines, a ...

Obese patients with type 2 diabetes are less likely to need a CPAP machine to treat sleep apnea if they’re taking a GLP-1 drug, researchers recently reported in JAMA Network Open. Patients were also ...

Respiratory and sleep medicine physicians share collaborative measures to diagnose and treat comorbid sleep disorders and ...

A nightly oral pill for obstructive sleep apnea is close to regulatory approval in the US. This medicine-based option could transform treatment for millions struggling with device therapies.

Medically reviewed by Sanja Jelic, MD Obstructive sleep apnea (OSA) is the most common form of sleep apnea.Central sleep ...

Research also suggests untreated sleep apnea is linked to a heightened risk of Parkinsons disease, a movement disorder ...

Beyond disrupting sleep, untreated OSA is linked to serious health risks, including high blood pressure, heart disease, stroke, and metabolic disorders. That’s why early recognition isn’t just about ...

As sleep apnea cases continue to rise across Canada, Air Voel remains committed to providing advanced CPAP machines that adapt to real life, not the other way around. By combining modern technology ...

Sleep apnea is increasingly common in India, yet few seek help. Factors like pollution and urban stress worsen sleep quality, leading to serious health risks.